Stuart Montgomery

31.5k total citations · 2 hit papers
335 papers, 23.9k citations indexed

About

Stuart Montgomery is a scholar working on Pharmacology, Psychiatry and Mental health and Experimental and Cognitive Psychology. According to data from OpenAlex, Stuart Montgomery has authored 335 papers receiving a total of 23.9k indexed citations (citations by other indexed papers that have themselves been cited), including 218 papers in Pharmacology, 142 papers in Psychiatry and Mental health and 106 papers in Experimental and Cognitive Psychology. Recurrent topics in Stuart Montgomery's work include Treatment of Major Depression (216 papers), Bipolar Disorder and Treatment (79 papers) and Tryptophan and brain disorders (70 papers). Stuart Montgomery is often cited by papers focused on Treatment of Major Depression (216 papers), Bipolar Disorder and Treatment (79 papers) and Tryptophan and brain disorders (70 papers). Stuart Montgomery collaborates with scholars based in United Kingdom, Italy and Austria. Stuart Montgomery's co-authors include Marie Åsberg, Siegfried Kasper, Julien Mendlewicz, Daniel Souery, Joseph Zohar, Daisy Schalling, C. Perris, Göran Sedvall, Alessandro Serretti and David S. Baldwin and has published in prestigious journals such as The Lancet, Biological Psychiatry and Annals of the New York Academy of Sciences.

In The Last Decade

Stuart Montgomery

324 papers receiving 22.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A New Depression Scale Designed to be Sensitive to Change

1979 11.1k citations Stuart Montgomery, Marie Åsberg profile →
A COMPREHENSIVE PSYCHOPATHOLOGICAL RATING SCALE

1978 1.1k citations Marie Åsberg, Stuart Montgomery et al. Acta Psychiatrica Scandinavica profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Stuart Montgomery	10.2k	9.5k	6.5k	4.8k	3.6k	335	23.9k
Marie Åsberg	9.0k 0.9×	6.1k 0.6×	4.6k 0.7×	7.5k 1.5×	3.2k 0.9×	222	25.1k
M. Hamilton	10.6k 1.0×	6.8k 0.7×	7.8k 1.2×	7.8k 1.6×	3.2k 0.9×	15	28.8k
Barry D. Lebowitz	9.7k 1.0×	6.2k 0.7×	3.0k 0.5×	3.7k 0.8×	3.0k 0.8×	149	20.2k
Jerrold F. Rosenbaum	6.6k 0.7×	6.7k 0.7×	5.9k 0.9×	6.6k 1.4×	2.7k 0.7×	258	20.0k
Andrew A. Nierenberg	5.4k 0.5×	9.5k 1.0×	5.0k 0.8×	2.5k 0.5×	4.1k 1.1×	117	17.3k
Benoit H. Mulsant	13.6k 1.3×	6.7k 0.7×	3.8k 0.6×	5.1k 1.1×	2.1k 0.6×	750	29.8k
Michael E. Thase	8.0k 0.8×	11.4k 1.2×	11.6k 1.8×	8.5k 1.8×	3.9k 1.1×	563	30.9k
Raymond W. Lam	6.6k 0.6×	5.2k 0.5×	3.7k 0.6×	2.9k 0.6×	2.5k 0.7×	476	18.8k
Andrew A. Nierenberg	11.3k 1.1×	4.7k 0.5×	4.2k 0.6×	5.5k 1.1×	2.8k 0.8×	445	21.2k
Alessandro Serretti	9.0k 0.9×	5.8k 0.6×	5.3k 0.8×	7.4k 1.5×	4.4k 1.2×	738	26.4k

Countries citing papers authored by Stuart Montgomery

Since Specialization

Citations

This map shows the geographic impact of Stuart Montgomery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Montgomery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Montgomery more than expected).

Fields of papers citing papers by Stuart Montgomery

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart Montgomery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Montgomery. The network helps show where Stuart Montgomery may publish in the future.

Co-authorship network of co-authors of Stuart Montgomery

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart Montgomery. A scholar is included among the top collaborators of Stuart Montgomery based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart Montgomery. Stuart Montgomery is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Luca, Antonina, Maria Luca, Siegfried Kasper, et al.. (2025). Mild motor signs and depression: more than just medication side effects?. European Archives of Psychiatry and Clinical Neuroscience. 276(2). 451–457.

Olgiati, Paolo, Siegfried Kasper, Joseph Zohar, et al.. (2024). Hypomanic symptoms in major depressive disorder: Prognostic impact and treatment issues. Journal of Affective Disorders. 369. 1021–1030. 2 indexed citations

Kautzky, Alexander, Lucie Bartova, Gernot Fugger, et al.. (2023). Age as a moderating factor of treatment resistance in depression. European Psychiatry. 66(1). e35–e35. 4 indexed citations

Calabrò, Marco, Chiara Fabbri, Siegfried Kasper, et al.. (2021). Research Domain Criteria (RDoC): A Perspective to Probe the Biological Background behind Treatment Efficacy in Depression. Current Medicinal Chemistry. 28(22). 4296–4320. 2 indexed citations

Bartova, Lucie, Gernot Fugger, Markus Dold, et al.. (2021). The Choice of Either Quetiapine or Aripiprazole as Augmentation Treatment in a European Naturalistic Sample of Patients With Major Depressive Disorder. The International Journal of Neuropsychopharmacology. 25(2). 118–127. 2 indexed citations

Dold, Markus, Lucie Bartova, Gernot Fugger, et al.. (2021). Melancholic features in major depression – a European multicenter study. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 110. 110285–110285. 22 indexed citations

Kautzky, Alexander, Markus Dold, Lucie Bartova, et al.. (2018). Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study. Acta Psychiatrica Scandinavica. 139(1). 78–88. 99 indexed citations

Kautzky, Alexander, Markus Dold, Lucie Bartova, et al.. (2017). Refining Prediction in Treatment-Resistant Depression. The Journal of Clinical Psychiatry. 79(1). 16m11385–16m11385. 58 indexed citations

Fabbri, Chiara, Agnese Marsano, Diego Albani, et al.. (2014). PPP3CC gene: a putative modulator of antidepressant response through the B-cell receptor signaling pathway. The Pharmacogenomics Journal. 14(5). 463–472. 35 indexed citations

10.

Montgomery, Stuart, et al.. (2014). A randomised, double‐blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin–noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine. Human Psychopharmacology Clinical and Experimental. 29(5). 470–482. 105 indexed citations

11.

Montgomery, Stuart, Aartjan T.F. Beekman, Joel Sadavoy, et al.. (2013). Consensus Statement on Depression in the Elderly. 2. 0–0.

12.

Kocabaş, Neslihan Aygün, Irina Antonijevic, Carlos Forray, et al.. (2010). Dysbindin gene (DTNBP1) in major depressive disorder (MDD) patients: Lack of association with clinical phenotypes. The World Journal of Biological Psychiatry. 11(8). 985–990. 3 indexed citations

13.

Souery, Daniel, Pierre Oswald, Isabelle Massat, et al.. (2007). Clinical Factors Associated With Treatment Resistance in Major Depressive Disorder. The Journal of Clinical Psychiatry. 68(7). 1062–1070. 371 indexed citations

14.

Allgulander, Christer, Borwin Bandelow, Eric Hollander, et al.. (2003). WCA Recommendations for the Long-Term Treatment of Generalized Anxiety Disorder. CNS Spectrums. 8(S1). 53–61. 78 indexed citations

15.

Hirschfeld, Robert M. A., Stuart Montgomery, Eugenio Aguglia, et al.. (2002). Partial Response and Nonresponse to Antidepressant Therapy. The Journal of Clinical Psychiatry. 63(9). 826–837. 148 indexed citations

16.

Montgomery, Stuart, et al.. (2001). Citalopram 20 mg, 40 mg and 60 mg are all effective and well tolerated compared with placebo in obsessive-compulsive disorder. International Clinical Psychopharmacology. 16(2). 75–86. 136 indexed citations

17.

Montgomery, Stuart. (1999). Social phobia: diagnosis, severity and implications for treatment. European Archives of Psychiatry and Clinical Neuroscience. 249(S1). S1–S6. 15 indexed citations

18.

Montgomery, Stuart, et al.. (1994). Psychopharmacology of depression. Oxford University Press eBooks. 38 indexed citations

19.

Altamura, A. Carlo, et al.. (1989). Fluoxetine compared with amitriptyline in elderly depression: a controlled clinical trial.. PubMed. 9(6). 391–6. 47 indexed citations

20.

Montgomery, Stuart, Börje Cronholm, Marie Åsberg, & D. Montgomery. (1978). Differential effects on suicidal ideation of mianserin, maprotiline and amitriptyline.. British Journal of Clinical Pharmacology. 5(S1). 77S–80S. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact